FDA Issues Alert for Geodon
The Carlat Psychiatry Report, Volume 13, Number 2, February 2015
https://www.thecarlatreport.com/newsletter-issue/tcprv13n2/
Issue Links: Learning Objectives | Editorial Information
Topics: Antipsychotics | News of Note
In December 2014, the US Food and Drug Administration (FDA) issued a safety announcement warning that the antipsychotic drug ziprasidone (Geodon) has been associated with a rare but potentially fatal skin reaction.
You can't view details of this content, please login or buy subscription here